Skip to main content
Anticholinergic/Antiparkinsonian Agent

Biperiden | Akineton

Clinical Overview

Biperiden is an anticholinergic agent indicated for the treatment of parkinsonism and drug-induced extrapyramidal disorders. It effectively counteracts muscarinic effects and is particularly valuable in managing movement disorders caused by antipsychotic medications, offering both oral and injectable formulations for different clinical situations.

Primary Clinical Applications

Biperiden is indicated for all forms of parkinsonism including idiopathic, postencephalitic, and arteriosclerotic types. It is especially effective in controlling drug-induced extrapyramidal symptoms such as acute dystonia, pseudoparkinsonism, and akathisia caused by neuroleptic medications.

Mechanism and Clinical Benefits

By blocking central muscarinic receptors, biperiden helps restore the dopamine-acetylcholine balance in the basal ganglia. This mechanism provides relief from tremor, rigidity, bradykinesia, and acute dystonic reactions while improving overall motor function and patient comfort.

Formulation Advantages

Available in both oral and injectable formulations, biperiden offers flexibility in treatment approaches. The injectable form is particularly valuable for acute dystonic reactions requiring rapid relief, while oral formulations are suitable for maintenance therapy and chronic conditions.

Prescribing Information

Dosing & Administration

Parkinsonism – Oral:

  • Initial: 1 mg twice daily
  • Titration: Increase by 2 mg daily every 2-3 days
  • Maintenance: 3-16 mg daily in divided doses
  • Maximum: 16 mg daily

Drug-Induced Extrapyramidal Symptoms:

  • Oral: 2-6 mg daily in divided doses
  • Acute dystonia (IM/IV): 2.5-5 mg, repeat if necessary

Elderly:

  • Start with lower doses (0.5-1 mg twice daily)
  • Titrate slowly based on response and tolerability

Indications

  • All forms of parkinsonism
  • Drug-induced extrapyramidal disorders
  • Acute dystonic reactions
  • Pseudoparkinsonism from antipsychotics

Contraindications

  • Narrow-angle glaucoma
  • Mechanical obstruction of GI or GU tract
  • Megacolon
  • Myasthenia gravis
  • Known hypersensitivity to biperiden

Warnings & Precautions

  • Anticholinergic effects: Monitor for confusion, especially in elderly
  • Heat stroke risk: Reduced sweating capability
  • Mental confusion: Euphoria, agitation in susceptible patients
  • Tardive dyskinesia: May mask symptoms
  • Glaucoma: Regular intraocular pressure monitoring
  • Prostate enlargement: Monitor for urinary retention

Drug Interactions

  • Anticholinergic drugs: Additive anticholinergic effects
  • Phenothiazines: May reduce antipsychotic efficacy
  • Tricyclic antidepressants: Enhanced anticholinergic toxicity
  • Digoxin: May increase absorption
  • Levodopa: May enhance therapeutic effects

Adverse Reactions

Common:

  • Dry mouth, blurred vision, constipation, urinary retention

CNS Effects:

  • Confusion, memory impairment, drowsiness, euphoria

Serious:

  • Anticholinergic toxicity, heat stroke, severe confusion

Special Populations

  • Elderly: Increased sensitivity to anticholinergic effects
  • Pregnancy: Use only if clearly needed
  • Hepatic impairment: Use with caution, monitor closely
  • Pediatric: Safety and efficacy not established
Medical Disclaimer: This information is for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare professionals before making any treatment decisions. Individual patient circumstances may vary significantly.